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Introduction
Autologous bone marrow transplantation (aBMT) is a
last resort treatment for patients with refractory juvenile
idiopathic arthritis (JIA). It can induce disease remission
for 80 months after transplantation. Unfortunately,
relapses also occur. The underlying working mechan-
isms remain largely unknown.
Objectives
We investigated the potential role of regulatory T cells
(Treg) during immune reconstitution and re-establishment
of immune tolerance following aBMT.
Methods
Arthritis was induced by two intraperitoneal injections
of proteoglycan (PG) in synthetic adjuvant dimethyl
dioctadecyl ammonium bromide (DDA), two and five
weeks before stem cell transplantation. The onset and
severity of arthritis were assessed three times a week in
a blinded fashion by a visual scoring system. Two weeks
after the second PG/DDA injection, a lethal dose of 7.5
Gy total body irradiation was given to arthritic mice.
Recipient mice were injected with 2 × 106 bone marrow
(BM) cells. GFP+Treg cells were sorted by flow cytome-
try as TCRb+ CD4+ CD25+ GFP+ T cells. Before infu-
sion, Treg suspensions were added to the bone marrow
graft in different amounts.
Results
In the PGIA mouse model, lethal irradiation followed by
aBMT, reduced arthritis scores and restored the
immune balance between pro-inflammatory effector T
cells and Treg. Directly following aBMT the majority of
Treg present, consisted of Treg that survived the condi-
tioning. Here after, the infused stem cell-derived Treg
started dominating the Treg pool and these “new” thy-
mus-derived Treg showed more suppressive capacity
than the remaining host Treg. A therapeutic approach
was initiated by infusing extra Foxp3GFPTreg together
with the stem cell graft. The infused Treg expanded vig-
orously in the first month after aBMT, followed by a
decrease in numbers in the second month. No extra
clinical improvement was found in the Treg-infused
groups, the highest Treg dosed group even showed an
increase in disease relapse. Both Treg treated groups
showed delayed induction of ‘ new’ stem cell derived
Treg.
Conclusion
These data indicate that restoration of the immune bal-
ance following aBMT depends on renewal of the natural
Treg pool derived from the injected stem cells. For now,
infusion of extra Treg during aBMT is not recom-
mended as this may delay T cell reconstitution and
development of long-term tolerance.
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